Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 15;61(20):3101-3106.
doi: 10.2169/internalmedicine.0104-22. Epub 2022 Aug 10.

A Novel Development of Sarcoidosis Following COVID-19 Vaccination and a Literature Review

Affiliations
Review

A Novel Development of Sarcoidosis Following COVID-19 Vaccination and a Literature Review

Tadahisa Numakura et al. Intern Med. .

Abstract

BNT162b2 (Pfizer/BioNTech) is a coronavirus disease 2019 (COVID-19) vaccine containing nucleoside-modified messenger RNA encoding the severe acute respiratory syndrome coronavirus 2 spike glycoprotein. Recently, ocular complications of mRNA vaccines have been reported increasingly frequently. However, immunological adverse events due to mRNA vaccines in real-world settings are not fully known. We herein report the novel development of sarcoidosis manifested as uveitis, bilateral hilar lymphadenopathy, angiotensin-converting enzyme elevation, and epithelioid and giant cell granuloma formation in the lung soon after the first BNT162b2 injection and review the current literature, including three reported cases of sarcoid-like reaction following COVID-19 vaccination.

Keywords: COVID-19; angiotensin-converting enzyme (ACE); mRNA vaccine; sarcoidosis; uveitis.

PubMed Disclaimer

Conflict of interest statement

The authors state that they have no Conflict of Interest (COI).

Figures

Figure 1.
Figure 1.
Timeline and the ocular manifestation of the current case. A: timeline of the current case. B: right corner nodules are indicated by arrows. C: right vitreous turbidity was present. D: left perivenous inflammation is indicated by arrows. rt: right, lt: left, BHL: bilateral hilar lymphadenopathy
Figure 2.
Figure 2.
Radiological and histopathologic findings of hilar and mediastinal lymphadenopathy. A: Chest X-ray (CXR) revealed marked bilateral hilar lymphadenopathy (BHL) on respiratory consultation. B: Normal CXR findings from the previous year. C: Contrast-enhanced chest computed tomography showed bilateral hilar and mediastinal lymphadenopathy. There were no remarkable findings in the lung parenchyma. D: Gallium (Ga)-67 scintigraphy showed an increased uptake in the ocular lesion (so-called panda sign) and bilateral hilar and mediastinal lymph nodes. E: Histopathological findings of a trans-bronchial lung biopsy (TBLB). A representative image of Hematoxylin and Eosin staining. A small non-caseating granuloma that consisted of tightly packed epithelioid cells (arrowheads), and a few admixed multinucleated giant cells (an arrow) and lymphocytes. Scale bar: 100 μm.

Similar articles

Cited by

References

    1. Drent M, Crouser ED, Grunewald J. Challenges of sarcoidosis and its management. N Engl J Med 385: 1018-1032, 2021. - PubMed
    1. Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet P-Y, Müller-Quernheim J. Sarcoidosis. Lancet 383: 1155-1167, 2014. - PubMed
    1. Chen ES, Moller DR. Etiologies of sarcoidosis. Clin Rev Allergy Immunol 49: 6-18, 2015. - PubMed
    1. Tamada T, Nara M, Murakami K, et al. . The clinical features of patients with sarcoidosis and malignant diseases in Japan. Intern Med 60: 209-216, 2021. - PMC - PubMed
    1. Chopra A, Nautiyal A, Kalkanis A, Judson MA. Drug-induced sarcoidosis-like reactions. Chest 154: 664-677, 2018. - PubMed